The following Minutes of Working Group (WG) Meetings are available:
- WG Methodologies:
- October 2010
- IN VITRO mutagenicity testing with the practical example of
dihydroxyacetone (DHA). The SCCS (see glossary)decided to dedicate a special discussion to:
- receive input on a concrete case example, and
- discuss in general how in vitro genotoxicity testing could be
improved to avoid an excess of false positive results
- ECVAM (see glossary)report of alternative methods and comments on the document
were collected
- work on the 7th revision of the Notes of Guidance
- November 2010
- COLIPA (The European Cosmetics Association) was invited to
present new studies on consumer exposure
- to cosmetic products and to discuss the results.
- deodorants/antiperspirants in aerosol form
- outcome of the ECVAM/EPPIA workshop on the 3T3 NRU
(Neutral Red Uptake) Phototoxicity test, and in particular the practical experience and
implications for phototoxicity testing
- final memorandum on Episkin for adoption December 2010.
(Available to subscribers from the download center).
- May 2011
- COLIPA was invited to present further information on safety assessments of cosmetic products to which consumers are exposed via the inhalation
- A SCCS member presented an introduction to Human Biomonitoring (see glossary: biomonitoring entry)and ongoing activities in the EU and worldwide
- Discussion on intestinal models to assess oral bioavailability
- WG Sensitisation and fragrances
- June 2011
- new text on pre- and pro-haptens.
-
SAR (see glossary) analyses of substances with
insufficient human data
- WG Cosmetic Ingredients
- July 2011
- Quaternium-15
- Arbutin / desoxyarbutin
- Lyral
- Dichloromethane
- Polidocanol
- Methyl N-methylanthranililate
- Climbazole
- Kojic acid
- Zinc pyrithione
- Benzoisothiazolinone
- Soytrimonium chloride
- Oxidised Vitamin K1
- justification for Danish ban of propyl and butyl
parabens in cosmetic products for children up to three years of age
